Aller au contenu principal
Accès ouvert déclaré 2026 article

Short- and long-term risk stratification in acutely ill medical patients by implementing D-dimer in the emergency setting – A prospective cohort study

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : at, be. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objective D-dimer testing is commonly used in emergency departments (EDs) to rule out thromboembolic events. However, elevated D-dimer levels may also be associated with an increased risk of mortality, independent of thromboembolism. Methods This prospective observational study enrolled acutely ill medical ED patients. D-dimer measurements were conducted as part of biobanking at ED presentation. Survival at 30, 90, and 360 days was analyzed in relation to D-dimer, and Receiver operating characteristic (ROC) curves and logistic regressions were performed. Results A total of 1035 patients were included (56% male; 61 years [IQR 46–74]). Median follow-up was 764 days (7.7% mortality). Elevated D-dimer (≥0.5 μg/mL) was observed in 46.4% of patients. Thirty-day mortality was 4.8% in patients with elevated D-dimer versus 0.2% with normal D-dimer levels (log-rank p < 0.001), while 360-day mortality was 13.5% versus 2.3% ( p < 0.001), respectively. Among discharged patients, 360-day mortality was 9.2% with elevated D-dimer vs. 0.7% with normal values (log-rank p < 0.001). The ROC-derived optimal cut-off for both time points was 0.75 μg/mL (AUC 0.82 and 0.76 for 30- and 360-day mortality). Multivariable analysis adjusted for age, BMI, and comorbidities yielded elevated D-dimer to remain an independent predictor of mortality. Conclusion In unselected ED patients, D-dimer independently predicts 30- and 360-day mortality. Beyond its diagnostic role for VTE, an elevated D-dimer—particularly in patients with no VTE and discharge from the ED—identifies individuals at increased short- and long-term risk. Incorporating D-dimer (e.g., ≥ 0.75 μg/mL) into routine risk stratification may support targeted follow-up and post-discharge management.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Short- and long-term risk stratification in acutely ill medical patients by implementing D-dimer in the emergency setting – A prospective cohort study
Date Crossref
01/05/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Medical University of Vienna Department of Emergency Medicine pays non établi dans la notice
    Université ou école supérieure
  • Antwerp University Hospital Department of Emergency Medicine pays non établi dans la notice
    Organisme public
  • Emergency Medical Service Vienna pays non établi dans la notice
    Organisme public

Department of Emergency Medicine — Medical University of Vienna, Department of Emergency Medicine — Antwerp University Hospital et Emergency Medical Service Vienna.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Sepsis Diagnosis and TreatmentNosocomial Infections in ICUImmune Response and Inflammation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.